Data / Form D filings / Altay Therapeutics, Inc.
Altay Therapeutics, Inc.: Form D filing
Altay Therapeutics, Inc., a biotechnology company in San Carlos, CA, filed a Form D with the SEC in 2026. The latest, on October 2, 2026, reports $15.7 million sold of a $45.1 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 733 INDUSTRIAL ROAD, San Carlos, CA, 94070
- Phone
- (650) 455-1147
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2157551
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 2 | New notice | $45,067,885 | $15,738,155 | $29,329,730 | 19 | Sep 17 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JAMES BREITMEYER | Executive Officer, Director | |
| ALI OZES | Executive Officer | |
| ERIC BJERKHOLT | Director | |
| MIKE GREY | Director | |
| ESTER SKLARSKY | Director | |
| AIDAN KING | Director | |
| CHELSEA JOHNSON | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $22.9 million · Oct 21
- Theravie Pharma, Inc. $750,000 · Oct 19
- Adela, Inc. $12 million · Oct 19
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16
- Renue Life Sciences, Inc. $250,000 · Oct 14
- Tempest Therapeutics, Inc. $7.5 million · Oct 14
Every Form D from the week of Sep 28 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Altay Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.